Fetal allogeneic umbilical cord cell transplantation improves motor function in spinal cord-injured rats;Allojenik fetal göbek kordonu hücrelerinin transplantasyonu omurilik hasarlı sıçanlarda motor fonksiyonu i̇yileştirir

Turkish Neurosurgery

Volumn 20, Issue 3, 2010, Pages 286-294

  Erdogan, Bulent ^a   Bavbek, Murad ^b   Sahin, Iffet Feride ^c   Caner, Hakan ^c   Ozen, Ozlem ^c   Denkbas, Emir Baki ^d   Altinors, Mehmet Nur ^c  

^a FATIH UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alginate gel; Allogeneic transplantation; Function recovery; Mesenchymal stem cells; Spinal cord injury; Umbilical cord cells

Indexed keywords

EID: 77956240458     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.JTN.3020-10.1     Document Type: Article

References (33)

1. Atalay B, Bavbek M, Cekinmez M, Ozen O, Nacar A, Karabay G, Gulsen S: Antibodies neutralizing Nogo-A increase pancadherin expression and motor recovery following spinal cord injury in rats. Spinal Cord 45: 780-786, 2007
2. Breymann C, Schmidt D, Hoerstrup SP: Umbilical cord cells as a source of cardiovascular tissue engineering. Stem Cell Rev 2: 87-92, 2006
3. Cao Q, Xu XM, Devries WH, Enzmann GU, Ping P, Tsoulfas P, Wood PM, Bunge MB, Whittemore SR: Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 25: 6947-6957, 2005
4. Cho SR, Yang MS, Yim SH, Park JH, Lee JE, Eom YW, Jang IK, Kim HE, Park JS, Kim HO, Lee BH, Park CI, Kim YJ: Neurally induced umbilical cord blood cells modestly repair injured spinal cords. Neuroreport 19: 1259-1263, 2008
5. Deda H, Inci MC, Kürekçi AE, Kayihan K, Ozgün E, Ustünsoy GE, Kocabay S: Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 10: 565-574, 2008
6. Gucciardo L, Lories R, Ochsenbein-Kölble N, Done E, Zwijsen A, Deprest J: Fetal mesenchymal stem cells: Isolation, properties and potential use in perinatology and regenerative medicine. 116: 166-172, 2009
7. Guest JD, Hiester ED, Bunge RP: Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 192: 384-393, 2005
8. Harris DT, Rogers I: Umbilical cord blood: A unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2: 301-309, 2007
9. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, Olson L: Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99: 2199-2204, 2002
10. Hulsebosch CE: Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26: 238-255, 2002
11. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J: Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96: 25-34, 1999
12. Kataoka K, Suzuki Y, Kitada M, Ohnishi K, Suzuki K, Tanihara M, Ide C, Endo K, Nishimura Y: Alginate, a bioresorbable material derived from brown seaweed, enhances elongation of amputated axons of spinal cord in infant rats. J Biomed Mater Res 54: 373-384, 2001
13. Lemons ML, Howland DR, Anderson DK: Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp Neurol 160: 51-65, 1999
14. Li Y, Field PM, Raisman G: Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277: 2000-2002, 1997
15. Low CB, LiouYC, Tang BL: Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy J Neurosci Res 86: 1670-1976, 2008
16. Mackay-Sim A, Féron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, Fronek P, Gray C, Kerr G, Licina P, Nowitzke A, Perry C, Silburn PA, Urquhart S, Geraghty T: Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131: 2376-2386, 2008
17. Martino G, Pluchino S: The therapeutic potential of neural stem cells. Nat Rev Neurosci 7: 395-406, 2006
18. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5: 1410-1412, 1999
19. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE: Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13: 805-811, 1994
20. Ogawa Y, Sawamoto K, Miyata T, Miyao S, Watanabe M, Nakamura M, Bregman BS, Koike M, Uchiyama Y, Toyama Y, Okano H: Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 69: 925-933, 2002
21. Okano H, Ogawa Y, Nakamura M, Kaneko S, Iwanami A, Toyama Y: Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Develop Biol 14: 191-198, 2003
22. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallén A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisén J: Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145: 503-514, 1999
23. Romanov YA, Svintsitskaya VA, Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells 21: 105-110, 2003
24. Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M, Raviolo V, Lituania M, Kunkl A, Ferlazzo G, Bricarelli FD, Uccelli A, Frassoni F: Multipotent mesenchymal stromal cells from amniotic fluid: Solid perspectives for clinical application. Hematologica 93: 339-346, 2008
25. Soy O, Aslan O, Uzun H, Barut S, Iǧdem AA, Belce A, Colak A: Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury. Acta Neurochir (Wien) 146: 1329-1335, 2004
26. Tuszynski MH, Peterson DA, Ray J, Baird A, Nakahara Y, Gage FH: Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol 126: 1-14, 1994
27. Wang GS, Zhang QZ, Han ZC: Evaluation of neurological function recovery following human umbilical cord mesenchymal stem cells transplantation to injured spinal cord in rats. Chin J Neurosurg (Chin) 22: 18-21, 2006
28. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC: Mesenchymal stem cells in the Wharton?s jelly of the human umbilical cord. Stem Cells 22: 1330-1337, 2004
29. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D: Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson?s disease. Stem Cells 24: 781-792, 2006
30. Widenfalk J, Lundströmer K, Jubran M, Brene S, Olson L: Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 21: 3457-3475, 2001
31. Willerth SM, Sakiyama-Elbert SE: Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev 60: 263-276, 2008
32. Vitellaro-Zuccarello L, Mazzetti S, Madaschi L, Bosisio P, Fontana E, Gorio A, De Biasi S: Chronic erythropoietinmediated effects on the expression of astrocyte markers in a rat model of contusive spinal cord injury. Neurosci 24; (151): 452-466, 2008
33. Xu XM, Guenard V, Kleitman N, Aebischer P, Bunge MB: A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 134: 261-272, 1995